503. Clonal Hematopoiesis, Aging, and Inflammation: Poster I

The CD33 SNP rs3865444 modulates the association of clonal hematopoiesis with Alzheimer s disease

Impact of innate immune memory on MDS progression by TET2 driven inflammation

Beyond clonal hematopoiesis of indeterminate potential Understanding how the trisomy 21 context promotes TET2 mutations

U2AF1S34F mutant HSPCs have a fitness advantage in aged and inflamed bone marrow

Longterm outcome of patients with clonal cytopenia of undetermined significance 10 year follow up of a large unselected cohort

Distinct patterns of clonal hematopoiesis exist in a longevity enriched cohort

Concurrent clonality of multiple hematopoietic lineages Implications for pathogenesis and management of cytopenia

The role of sole loss of chromosome y in myeloid neoplasms

Asxl1 mutant cells suppress Dnmt3a mutant clonal expansion

Srsf2P95H and Nf1 deficiency synergistically activate JAK STAT signaling and exacerbate age related clonal hematopoiesis in mice

Prevalence and significance of cytoses in clonal hematpoiesis

A pre NGS screening strategy to identify populations with high risk clonal hematopoiesis